Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

404 trials

NCT07108920
Recruiting
Analysis of Balance Disorders After Botulinum Toxin Treatment in the Rectus Femoris in Patients With a Stiff Knee Gait
Not applicable · France · 1 site
Registry update: 22 Sept 2025
2024-517745-14-00
Recruiting
Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368, a FAAH/MAGL Inhibitor, in Participants with Multiple Sclerosis Spasticity
Phase 2 · Czechia, Germany, Poland · 22 sites
Registry update: 30 Oct 2026
NCT06463743
Recruiting
Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)
Phase 2 · United States · 1 site
Registry update: 6 Nov 2026
NCT07012135
Recruiting
Deciphering Preserved Autonomic Function After Multiple Sclerosis
Not applicable · United States · 1 site
Registry update: 28 May 2026
2024-520287-34-01
Recruiting
A phase II randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of an oral solution of 9-Δ tetrahydrocannabinol/cannabidiol (THC/CBD) in multiple sclerosis patients with chronic neuropathic pain
Phase 2 · Portugal · 1 site
Registry update: 23 Feb 2026
2024-512914-16-00
Recruiting
A Randomized, Double-blind, Study to Demonstrate Pharmacokinetic Similarity, and Evaluate Safety, Immunogenicity, Pharmacodynamics and Clinical Effects between ABP 692 and Ocrevus® (Ocrelizumab) in Subjects with Relapsing-remitting Multiple Sclerosis
Phase 3 · Belgium, Bulgaria, Czechia, Germany, Denmark, Spain, France, Croatia, Italy, Lithuania, Poland, Romania, Sweden, Slovenia, Slovakia · 55 sites
Registry update: 20 Oct 2026
Conflicting statuses (updated in the registry within the last month)
NCT07544303
Recruiting
Fatigue and Mental Well-Being in MS Patients(Multiple Sclerosis)
Not applicable · 1 site
Registry update: 22 Apr 2026
NCT06951919
Recruiting
HOBSCOTCH-MS-Efficacy Trial
Not applicable · United States · 1 site
Registry update: 2 Nov 2026
NCT07630311
Recruiting
"Balance, Gait, and Motion Analysis in Multiple Sclerosis"
Not applicable · Greece · 2 sites
Registry update: 24 Jun 2026
NCT06968676
Recruiting
Mixed Reality for Upper Limb Rehabilitation in People With Multiple Sclerosis (VIRTUALDOMUS)
Not applicable · Spain · 1 site
Registry update: 5 May 2026
NCT07492667
Recruiting
Comparison of the Performance of the 2024 and 2017 McDonald Criteria for the Diagnosis of Multiple Sclerosis in Real Life
Not applicable · France · 2 sites
Registry update: 25 Mar 2026
NCT07167680
Recruiting
Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters
Not applicable · United States · 1 site
Registry update: 11 May 2026
NCT07183683
Recruiting
Stimulation of Acupuncture Points in Female Patients With Multiple Sclerosis and Neurogenic Bladder Dysfunction
Not applicable · Germany · 1 site
Registry update: 19 Sept 2025
NCT07115017
Recruiting
This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis.
Not applicable · United States · 1 site
Registry update: 4 Aug 2026
NCT06453694
Recruiting
Efgartigimod for the Treatment of Acute Optic Neuritis
Phase 2 · United States · 2 sites
Registry update: 28 Oct 2026
NCT06901687
Recruiting
Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)
Phase 2 · United States · 1 site
Registry update: 29 Jun 2026
NCT07151534
Recruiting
Body Awareness, Trunk Stability, and Arm Function in MS
Not applicable · 1 site
Registry update: 17 Sept 2026
NCT07139743
Recruiting
Obe-cel in Refractory Progressive Forms of Multiple Sclerosis
Phase 1 · Spain, United Kingdom, United States · 7 sites
Registry update: 16 Oct 2026
NCT07085507
Recruiting
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VT7208 in Healthy Participants and MS Patients
Phase 1/2 · Australia · 1 site
Registry update: 21 Jul 2026
NCT07002034
Recruiting
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Phase 2 · United States · 32 sites
Registry update: 15 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.